Turk İlaç and Serum Sanayi A.Ş. made a statement regarding the negotiations on the production of Covid-19 vaccine.
Public Disclosure Platform (KAP) made the following statement: "our company Covidien-19 vaccine of information regarding the interview conducted for the production in Turkey 4.3.2021 the Board of Directors of the board with the decision of II-15.1 No. exceptions to postpone described under Article 6 of the notification the decision was taken. In line with the new developments, it was decided to authorize Board Chairman Mehmet Berat Battal with the decision of the Board of Directors dated 19 and numbered 29.3.2021/2021 in order to bring an institutional status to the negotiations conducted by our company for the production of Covid-014 vaccine. "